Submit Content
Get the latest delivered to your inbox
Privacy Policy

Bristol-Myers Squibb Company

Bristol-Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. For more information, please visit www.bms.com or follow us on Twitter at http://twitter.com/bmsnews.

     Basketball Legend Kareem Abdul-Jabbar Joins No Time to Wait Campaign to Raise Awareness of Atrial Fibrillation (AFib) and its Symptoms Image

    POSTED 

    02-22-23

    Basketball Legend Kareem Abdul-Jabbar Joins No Time to Wait Campaign to Raise Awareness of Atrial Fibrillation (AFib) and its Symptoms

    Kareem Abdul-Jabbar is teaming up with Bristol Myers Squibb and Pfizer to raise awareness of atrial fibrillation (AFib) and its symptoms as part of the No Time to Wait campaign.
    Reflecting on Research in Genitourinary Cancers Image

    POSTED 

    02-07-23

    Reflecting on Research in Genitourinary Cancers

    Hi, my name is Dana Walker. I’m the development program lead for genitourinary cancers here at Bristol Myers Squibb. I’m proud to lead a team of people continuing to develop treatments that help improve and extend the lives of patients dealing with genitourinary cancers.
    The Power of Dual Immunotherapy Image

    POSTED 

    01-30-23

    The Power of Dual Immunotherapy

    A decade ago, the evolution of immuno-oncology transformed the landscape of therapy for patients with many cancers. Although individual immunotherapies have helped to improve outcomes for patients.
    The Robert A. Winn Diversity in Clinical Trials Award Program Established by the Bristol Myers Squibb Foundation To Expand With Amgen’s Commitment of $8 Million Image

    POSTED 

    01-20-23

    The Robert A. Winn Diversity in Clinical Trials Award Program Established by the Bristol Myers Squibb Foundation To Expand With Amgen’s Commitment of $8 Million

    The Robert A. Winn Diversity in Clinical Trials Award Program (Winn Award Program) established by the Bristol Myers Squibb Foundation (BMSF) announced that Amgen, a global biotechnology company, has committed to contribute $8 million over the next four years.
    Biking the Globe for C2C4C Image

    POSTED 

    01-06-23

    Biking the Globe for C2C4C

    A handful of inspirational words from author Scott Stoll served as the rallying cry for more than 350 Bristol Myers Squibb employees representing 23 nations who successfully trained and participated in four regional bicycle rides collectively known as C2C4C.
    Moments of Serendipity As Our Teams 'Light the Night' Image

    POSTED 

    12-21-22

    Moments of Serendipity As Our Teams 'Light the Night'

    The experience was “miraculous” for Asalia, and this story is one of countless from the annual walks that support the Leukemia and Lymphoma Society (LLS), with which Bristol Myers Squibb has had a long-standing partnership.
    Cancer Care Milestone Reached in Lesotho Image

    POSTED 

    12-07-22

    Cancer Care Milestone Reached in Lesotho

    For too many years, cancer patients in Lesotho felt life-changing cancer treatment was out of reach. No oncology clinics existed in their landlocked country ringed by steep mountains and surrounded by South Africa.
    Lung Cancer Is Personal: Interview With Lee James Image

    POSTED 

    11-09-22

    Lung Cancer Is Personal: Interview With Lee James

    Each November marks Lung Cancer Awareness Month in the United States. Lung cancer is the leading cause of cancer deaths in the country, taking more lives than breast, colon and prostate cancers combined.
    A Beacon of Hope Image

    POSTED 

    11-02-22

    A Beacon of Hope

    Bristol Myers Squibb has a long-standing partnership with The Leukemia & Lymphoma Society (LLS) and has been the top biopharma fundraising team for Light The Night® for more than a decade.
    The Robert A. Winn Diversity in Clinical Trials Award Program Announces the Second Group of Physicians to be Trained in the $114 Million Program Image

    POSTED 

    10-26-22

    The Robert A. Winn Diversity in Clinical Trials Award Program Announces the Second Group of Physicians to be Trained in the $114 Million Program

    The Bristol Myers Squibb Foundation (BMSF) announced that an additional 64 physicians have been selected to receive the Robert A. Winn Diversity in Clinical Trials Career Development Award (Winn CDA).
    Bristol-Myers Squibb Company Logo

    Bristol-Myers Squibb Company

    Bristol-Myers Squibb Company

    Join today and get the latest delivered to your inbox